Diagnostics, Efficacy, and Safety of Immunomodulatory and Anti-Fibrotic Treatment for Interstitial Lung Disease Associated with Systemic Scleroderma (SSc-ILD)
- DOI
- 10.3390/diagnostics15172243
- Published
- 2025-09-04
- Container
- Diagnostics
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/diagnostics15172243,
title = {Diagnostics, Efficacy, and Safety of Immunomodulatory and Anti-Fibrotic Treatment for Interstitial Lung Disease Associated with Systemic Scleroderma (SSc-ILD)},
author = {Dawid Piecuch and Edyta Hanczyk and Katarzyna Zemsta and Michał Zwoliński and Szymon Kopciał and Joanna Jońska},
year = {2025},
journal = {Diagnostics},
doi = {10.3390/diagnostics15172243},
url = {https://doi.org/10.3390/diagnostics15172243}
}RIS
TY - JOUR TI - Diagnostics, Efficacy, and Safety of Immunomodulatory and Anti-Fibrotic Treatment for Interstitial Lung Disease Associated with Systemic Scleroderma (SSc-ILD) AU - Dawid Piecuch AU - Edyta Hanczyk AU - Katarzyna Zemsta AU - Michał Zwoliński AU - Szymon Kopciał AU - Joanna Jońska PY - 2025 JO - Diagnostics DO - 10.3390/diagnostics15172243 UR - https://doi.org/10.3390/diagnostics15172243 ER -
APA
Piecuch, D., Hanczyk, E., Zemsta, K., Zwoliński, M., Kopciał, S., & Jońska, J. (2025). Diagnostics, Efficacy, and Safety of Immunomodulatory and Anti-Fibrotic Treatment for Interstitial Lung Disease Associated with Systemic Scleroderma (SSc-ILD). Diagnostics. https://doi.org/10.3390/diagnostics15172243
Source records
- crossref · retrieved 2026-09-25T12:57:17.713Z